Optic neuritis in a child with biotinidase deficiency: Case report and literature review

Clinical Ophthalmology

Volumn 6, Issue 1, 2012, Pages 389-395

  Hayati, Abdul Aziz ^a   Wan Hitam, Wan Hazabbah ^a   Cheong, Min Tet ^a   Yunus, Rohaizan ^a   Shatriah, Ismail ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Biotinidase deficiency; Children; Optic neuritis

Indexed keywords

3 HYDROXYISOVALERIC ACID; ANTICONVULSIVE AGENT; BIOTIN; BIOTINIDASE; HYDRACRYLIC ACID; ISOVALERIC ACID; METHYLPREDNISOLONE; PREDNISOLONE; SALBUTAMOL; UNCLASSIFIED DRUG;

AFFERENT PUPILLARY DEFECT; ARTICLE; ASTHMA; BIOTINIDASE DEFICIENCY; BLOOD EXAMINATION; BLOOD LEVEL; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILD; COLOR VISION DEFECT; DEVELOPMENTAL DISORDER; DISEASE DURATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; ENZYME ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; ETHNIC GROUP; EVOKED VISUAL RESPONSE; EYE EXAMINATION; FOLLOW UP; HEADACHE; HUMAN; IMPETIGO; MALAY; MALE; MEDICAL HISTORY; METERED DOSE INHALER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPHTHALMOSCOPY; OPTIC NERVE DISEASE; OPTIC NEURITIS; ORBIT DISEASE; PATIENT COMPLIANCE; PATIENT MONITORING; PERIMETRY; PHYSICAL EXAMINATION; PRESCHOOL CHILD; RECURRENT DISEASE; RETROORBITAL PAIN; SEIZURE; SEROLOGY; SKIN SCAR; TREATMENT DURATION; TREATMENT RESPONSE; URINE LEVEL; VISUAL ACUITY; VISUAL DISORDER; VITAMIN BLOOD LEVEL;

EID: 84859522891     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S29048     Document Type: Article

References (15)

1. Salbert BA, Astruc J, Wolf B. Ophthalmologic findings in biotinidase deficiency. Ophthalmologica. 1993;206(4):177-181.
2. Rahman S, Standing S, Dalton RN, Pike MG. Late presentation of biotinidase deficiency with acute visual loss and gait disturbance. Dev Med Child Neurol. 1997;39(12):830-831.
3. Lott IT, Lottenberg S, Nyhan WL, Buchsbaum MJ. Cerebral metabolic change after treatment in biotinidase deficiency. J Inherit Metab Dis. 1993;16(2):399-407.
4. Wolf B, Pomponio RJ, Norrgard KJ, et al. Delayed-onset profound biotinidase deficiency. J Pediatr. 1998;132(2):362-365.
5. Ramaekers VT, Suormala TM, Brab M, Duran R, Heimann G, Baumgartner ER. A biotinidase Km variant causing late onset bilateral optic neuropathy. Arch Dis Child. 1992;67(1):115-119.
6. Campana G, Valentini G, Legnaioli MI, Giovannucci-Uzielli ML, Pavari E. Ocular aspects in biotinidase deficiency. Clinical and genetic original studies. Ophthalmic Paediatr Genet. 1987;8(2):125-129.
7. Coşkun T, Tokatli A, Ozalp I. Inborn errors of biotin metabolism. Clinical and laboratory features of eight cases. Turk J Pediatr. 1994;36(4):267-278.
8. Wolf B, Heard GS, Weissbecker KA, McVoy JR, Grier RE, Leshner RT. Biotinidase deficiency: initial clinical features and rapid diagnosis. Ann Neurol. 1985;18(5):614-617.
9. Puertas Bordallo D, Martín Reyes C, Ruiz-Falcó Rojas ML, Duat Rodríguez A, Valls Ferrán MI. Optic neuropathy in biotinidase deficiency. Arch Soc Esp Oftalmol. 2004;79(8):393-396. Spanish.
10. Yang Y, Li C, Qi Z, et al. Spinal cord demyelination associated with biotinidase deficiency in 3 Chinese patients. J Child Neurol. 2007;22(2):156-160.
11. PubMed. gov. National Center for Biotechnology Information, US National Library of Medicine, National Institutes of Health.
12. Huizing M, Brooks BP, Anikster Y. Optic atrophies in metabolic disorders. Mol Genet Metab. 2005;86(1-2):51-60.
13. Tischler ME. Biotin (Biotinidase) deficiency. University of Arizona. Available from: htttp://www.wohproject.org/pdfs/biotin-deficiency.pdf.
14. National Eye Institute (NEI). Optic Neuritis Treatment Trial. In: ClinicalTrials. gov [website on the Internet]. Bethesda, MD: US National Library of Medicine; 1999 [updated June 2, 2006]. Available from: http://clinicaltrials.gov/ct2/show/NCT00000146. NLM identifier: NCT00000146. Accessed March 1, 2012.
15. Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109(12):1673-1678.